Ms Jaclyn Rubinstein, | |
300 W 55th St Apt 8m, New York, NY 10019-5167 | |
(516) 241-0190 | |
Not Available |
Full Name | Ms Jaclyn Rubinstein |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 300 W 55th St Apt 8m, New York, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003231291 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 022763 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Jaclyn Rubinstein, 300 W 55th St Apt 8m, New York, NY 10019-5167 Ph: () - | Ms Jaclyn Rubinstein, 300 W 55th St Apt 8m, New York, NY 10019-5167 Ph: (516) 241-0190 |
News Archive
Imagine a surgical patient on a blood-thinning drug who starts bleeding more than expected, and an antidote that works immediately - because the blood thinner and antidote were designed to work together. Researchers at Duke University Medical Center have engineered a way to do this for an entire, versatile class of drugs called aptamers and published their findings in Nature Medicine.
Not sure what's in—and not in—the new healthcare legislation signed into law by President Barack Obama in March? You're not alone. More than 2,100 adults were given a list of 18 reform items and asked to identify what's included and what's not included in the law. Only four items were correctly identified by the majority of those polled.
Taro Pharmaceutical Industries Ltd. today announced that the Supreme Court of the State of Israel (the "Supreme Court") has ruled that Sun Pharmaceutical Industries Ltd. ("Sun") may not exercise a warrant to purchase additional Taro shares while a previously ordered temporary injunction remains in effect.
The University of Bristol has been awarded £2.7 million by the Medical Research Council (MRC) to create a new research centre which will apply knowledge from genetic analyses to large-scale studies of the health of the population. These investigations will aim to find the factors that are causing disease, which can then be influenced to reduce risk.
The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.
› Verified 8 days ago
Meredith A Wright, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 227 Madison St, New York, NY 10002 Phone: 212-238-5025 | |
Jacqueline Christine Dolson-shewchuk, MSLP CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 241 W 72nd St # 2, New York, NY 10023 Phone: 212-580-1910 Fax: 212-580-1910 | |
Ms. Amy Lynn Kerner, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1410 York Ave, Apt 4c, New York, NY 10021 Phone: 212-988-4221 | |
Miss Karen Elizabeth Sullivan, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 E 104th St, New York, NY 10029 Phone: 212-289-4872 | |
Ms. Martha J Perl, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 123 W 77th St, Apt 2b, New York, NY 10024 Phone: 917-446-4027 | |
Mrs. Olga L Ruiz, MS. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 328 E 62nd St, New York, NY 10065 Phone: 212-752-7575 Fax: 212-752-7533 | |
Mrs. Erica Hyman, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 708 3rd Ave, 6th Floor, New York, NY 10017 Phone: 646-776-5675 |